» Articles » PMID: 28444875

Methylglyoxal-induced Apoptosis is Dependent on the Suppression of C-FLIP Expression Via Down-regulation of P65 in Endothelial Cells

Overview
Journal J Cell Mol Med
Date 2017 Apr 27
PMID 28444875
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Methylglyoxal (MGO) is a reactive dicarbonyl metabolite of glucose, and its plasma levels are elevated in patients with diabetes. Studies have shown that MGO combines with the amino and sulphhydryl groups of proteins to form stable advanced glycation end products (AGEs), which are associated with vascular endothelial cell (EC) injury and may contribute to the progression of atherosclerosis. In this study, MGO induced apoptosis in a dose-dependent manner in HUVECs, which was attenuated by pre-treatment with z-VAD, a pan caspase inhibitor. Treatment with MGO increased ROS levels, followed by dose-dependent down-regulation of c-FLIP . In addition, pre-treatment with the ROS scavenger NAC prevented the MGO-induced down-regulation of p65 and c-FLIP , and the forced expression of c-FLIP attenuated MGO-mediated apoptosis. Furthermore, MGO-induced apoptotic cell death in endothelium isolated from mouse aortas. Finally, MGO was found to induce apoptosis by down-regulating p65 expression at both the transcriptional and posttranslational levels, and thus, to inhibit c-FLIP mRNA expression by suppressing NF-κB transcriptional activity. Collectively, this study showed that MGO-induced apoptosis is dependent on c-FLIP down-regulation via ROS-mediated down-regulation of p65 expression in endothelial cells.

Citing Articles

Baicalin: a potential therapeutic agent for acute kidney injury and renal fibrosis.

Li X, Xu R, Zhang D, Cai J, Zhou H, Song T Front Pharmacol. 2025; 16:1511083.

PMID: 39911847 PMC: 11795133. DOI: 10.3389/fphar.2025.1511083.


Methylglyoxal in Cardiometabolic Disorders: Routes Leading to Pathology Counterbalanced by Treatment Strategies.

Berdowska I, Matusiewicz M, Fecka I Molecules. 2023; 28(23).

PMID: 38067472 PMC: 10708463. DOI: 10.3390/molecules28237742.


The role of protein kinase C in diabetic microvascular complications.

Pan D, Xu L, Guo M Front Endocrinol (Lausanne). 2022; 13:973058.

PMID: 36060954 PMC: 9433088. DOI: 10.3389/fendo.2022.973058.


Retracted Article: LncRNA OIP5-AS1 contributes to ox-LDL-induced inflammation and oxidative stress through regulating the miR-128-3p/CDKN2A axis in macrophages.

Li X, Cao Q, Wang Y, Wang Y RSC Adv. 2022; 9(71):41709-41719.

PMID: 35541591 PMC: 9076472. DOI: 10.1039/c9ra08322g.


Secretory activity of the coronary artery endothelial cells in conditions of the peritoneal dialysis.

Misian M, Baum E, Breborowicz A Ren Fail. 2022; 44(1):54-61.

PMID: 35174782 PMC: 8856042. DOI: 10.1080/0886022X.2021.2023024.


References
1.
Thornalley P, Langborg A, Minhas H . Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J. 1999; 344 Pt 1:109-16. PMC: 1220620. View

2.
Antognelli C, Mezzasoma L, Fettucciari K, Talesa V . A novel mechanism of methylglyoxal cytotoxicity in prostate cancer cells. Int J Biochem Cell Biol. 2013; 45(4):836-44. DOI: 10.1016/j.biocel.2013.01.003. View

3.
Liu J, Mak T, Banigesh A, Desai K, Wang R, Wu L . Aldolase B knockdown prevents high glucose-induced methylglyoxal overproduction and cellular dysfunction in endothelial cells. PLoS One. 2012; 7(7):e41495. PMC: 3404030. DOI: 10.1371/journal.pone.0041495. View

4.
Shipanova I, Glomb M, Nagaraj R . Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct. Arch Biochem Biophys. 1997; 344(1):29-36. DOI: 10.1006/abbi.1997.0195. View

5.
Chan W, Wu H . Methylglyoxal and high glucose co-treatment induces apoptosis or necrosis in human umbilical vein endothelial cells. J Cell Biochem. 2007; 103(4):1144-57. DOI: 10.1002/jcb.21489. View